Allogeneic Umbilical Cord MSCs for Liver Cirrhosis: Phase I Trial Results and Hepatic Artery Delivery
A 2026 Phase I trial shows umbilical cord stem cells delivered directly to the liver can reverse cirrhosis markers.
Read More »Immunotherapie and Immunology news
A 2026 Phase I trial shows umbilical cord stem cells delivered directly to the liver can reverse cirrhosis markers.
Read More »A 2026 meta-analysis of 15 RCTs shows MSCs cut acute GvHD incidence by 53% and chronic GvHD by 50%. A biomarker-guided trial identifies which transplant patients benefit most — and a cell-free exosome approach may be next.
Read More »How Much Does Stem Cell Therapy Cost in Thailand? Stem cell therapy in Thailand costs $3,500–$40,000 USD, depending on the treatment type, number of cells used, and protocol complexity. This is 50–70% less than equivalent treatments in the United States, Europe, or Australia — without compromising on quality or safety standards. Cost Breakdown by Treatment […]
Read More »Your body’s stem cell population drops dramatically after 40. Here’s what the science says about why we age — and how regenerative medicine is fighting back.
Read More »Your gut bacteria directly control how well your stem cells work. Here’s what every patient should know before treatment.
Read More »A technical review of 3D bioprinting for cartilage repair: thiolated bioinks, scaffold optimization, MSC chondrogenesis, and the path to clinical translation.
Read More »